Home > Request Information
Title:
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh